Lexicon Pharmaceuticals Inc (LXRX)
0.8634
+0.09
(+11.88%)
USD |
NASDAQ |
Nov 22, 16:00
0.8755
+0.01
(+1.40%)
After-Hours: 20:00
Lexicon Pharmaceuticals Cash from Financing (Quarterly): -0.916M for Sept. 30, 2024
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -0.916M |
| June 30, 2024 | -0.014M |
| March 31, 2024 | 239.38M |
| December 31, 2023 | -0.001M |
| September 30, 2023 | -0.21M |
| June 30, 2023 | 189.00M |
| March 31, 2023 | -0.824M |
| December 31, 2022 | 24.91M |
| September 30, 2022 | 94.02M |
| June 30, 2022 | 0.00 |
| March 31, 2022 | 23.28M |
| December 31, 2021 | -11.32M |
| September 30, 2021 | 19.78M |
| June 30, 2021 | -0.023M |
| March 31, 2021 | 14.27M |
| December 31, 2020 | 64.15M |
| September 30, 2020 | -210.12M |
| June 30, 2020 | -0.425M |
| March 31, 2020 | -1.244M |
| December 31, 2019 | -0.322M |
| September 30, 2019 | -0.32M |
| June 30, 2019 | -0.322M |
| March 31, 2019 | -1.262M |
| December 31, 2018 | -0.139M |
| September 30, 2018 | -0.356M |
| Date | Value |
|---|---|
| June 30, 2018 | -0.221M |
| March 31, 2018 | -1.528M |
| December 31, 2017 | 147.84M |
| September 30, 2017 | -0.498M |
| June 30, 2017 | 3.69M |
| March 31, 2017 | -1.104M |
| December 31, 2016 | 0.16M |
| September 30, 2016 | 1.684M |
| June 30, 2016 | 0.071M |
| March 31, 2016 | -0.928M |
| December 31, 2015 | -0.471M |
| September 30, 2015 | -0.353M |
| June 30, 2015 | -0.378M |
| March 31, 2015 | -0.83M |
| December 31, 2014 | 285.66M |
| September 30, 2014 | -0.266M |
| June 30, 2014 | -0.36M |
| March 31, 2014 | -1.231M |
| December 31, 2013 | -0.112M |
| September 30, 2013 | 0.022M |
| June 30, 2013 | -0.288M |
| March 31, 2013 | -1.011M |
| December 31, 2012 | 36.82M |
| September 30, 2012 | 0.407M |
| June 30, 2012 | -0.129M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-210.12M
Minimum
Sep 2020
239.38M
Maximum
Mar 2024
22.17M
Average
-0.0075M
Median
Cash from Financing (Quarterly) Benchmarks
| Viatris Inc | -1.637B |
| Halozyme Therapeutics Inc | 18.56M |
| Perspective Therapeutics Inc | 0.628M |
| Quanterix Corp | -0.328M |
| Autonomix Medical Inc | 0.00 |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -53.62M |
| Cash from Investing (Quarterly) | 53.47M |
| Free Cash Flow | -208.39M |
| Free Cash Flow Per Share (Quarterly) | -0.1492 |
| Free Cash Flow to Equity (Quarterly) | -54.32M |
| Free Cash Flow Yield | -83.02% |